Authors:
Van de Wiele, CV
Dumont, F
Dierckx, RA
Peers, SH
Thornback, JR
Slegers, G
Thierens, H
Citation: Cv. Van De Wiele et al., Biodistribution and dosimetry of Tc-99m-RP527, a gastrin-releasing peptide(GRP) agonist for the visualization of GRP receptor-expressing malignancies, J NUCL MED, 42(11), 2001, pp. 1722-1727
Authors:
Caveliers, V
Goodbody, AE
Tran, LL
Peers, SH
Thornback, JR
Bossuyt, A
Citation: V. Caveliers et al., Evaluation of Tc-99m-RP128 as a potential inflammation imaging agent: Human dosimetry and first clinical results, J NUCL MED, 42(1), 2001, pp. 154-161
Citation: Jf. Valliant et al., The solid phase synthesis and NMR spectroscopy of a Tc-99 chelate-bombesinderived peptide conjugate, INORG CHIM, 325(1-2), 2001, pp. 155-163
Authors:
Wong, E
Bennett, S
Lawrence, B
Fauconnier, T
Lu, LFL
Bell, RA
Thornback, JR
Eshima, D
Citation: E. Wong et al., Tuftsin receptor-binding peptide labeled with technetium: Chemistry and preliminary in vitro receptor-binding study, INORG CHEM, 40(22), 2001, pp. 5695
Authors:
Zhang, XG
Su, ZF
Ballinger, JR
Rauth, AM
Pollak, A
Thornback, JR
Citation: Xg. Zhang et al., Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: Effect of lipophilicity, BIOCONJ CHE, 11(3), 2000, pp. 401-407
Authors:
Dunn-Dufault, R
Pollak, A
Fitzgerald, J
Thornback, JR
Ballinger, JR
Citation: R. Dunn-dufault et al., A solid-phase technique for preparation of no-carrier-added technetium-99mradiopharmaceuticals: Application to the streptavidin/biotin system, NUCL MED BI, 27(8), 2000, pp. 803-807
Authors:
Paul, C
Peers, SH
Woodhouse, LE
Thornback, JR
Goodbody, AE
Bolton, C
Citation: C. Paul et al., The detection and quantitation of inflammation in the central nervous system during experimental allergic encephalomyelitis using the radiopharmaceutical Tc-99m-RP128, J NEUROSC M, 98(1), 2000, pp. 83-90
Authors:
Eshima, D
Fauconnier, T
Eshima, L
Thornback, JR
Citation: D. Eshima et al., Radiopharmaceuticals for lymphoscintigraphy: Including dosimetry and radiation considerations, SEM NUC MED, 30(1), 2000, pp. 25-32
Authors:
Dunn-Dufault, R
Pollak, A
Thornback, JR
Ballinger, JR
Citation: R. Dunn-dufault et al., Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technology, BIOCONJ CHE, 10(5), 1999, pp. 832-837
Authors:
Su, ZF
Zhang, XG
Ballinger, JR
Rauth, AM
Pollak, A
Thornback, JR
Citation: Zf. Su et al., Synthesis and evaluation of two technetium-99m-labeled peptidic e-nitroimidazoles for imaging hypoxia, BIOCONJ CHE, 10(5), 1999, pp. 897-904
Authors:
Pollak, A
Roe, DG
Pollock, CM
Lu, LFL
Thornback, JR
Citation: A. Pollak et al., A convenient method of preparing high specific activity technetium complexes using thiol-containing chelators adsorbed on gold, J AM CHEM S, 121(49), 1999, pp. 11593-11594